<DOC>
	<DOCNO>NCT02188654</DOCNO>
	<brief_summary>Psoriatic arthritis ( PsA ) systemic , inflammatory disease . The chronic inflammation PsA predispose patient metabolic syndrome ( MetS ) . MetS associate systemic inflammation proinflammatory cytokine . Clinical observation experimental result argue anti-inflammatory immunosuppressant property MET .</brief_summary>
	<brief_title>Metformin Psoriatic Arthritis</brief_title>
	<detailed_description>The chronic inflammatory nature psoriasis PsA predispose patient cardiovascular disease metabolic syndrome ( MetS ) . MetS associate systemic inflammation proinflammatory cytokines.Clinical observation experimental result argue anti-inflammatory immunosuppressant property MET . A randomized placebo-controlled trial conduct evaluate efficacy safety metformin add-on therapy MTX compare MTX 24 week patient PsA . The study randomize 56 patient diagnosis PsA . Patients history cardiovascular event diabetic exclude . Body mass index ( BMI ) classic cardiovascular risk factor record . Blood sample analyse glucose , lipid profile , ESR , hsCRP , proinflammatory cytokine ; tumour necrosis factor alpha ( TNF-alpha ) , interleukin-6 ( IL-6 ) IL-17 . The homeostasis model assessment model insulin resistance ( HOMA-IR ) use . The patient randomize 1:1 ratio receive 500mg/day retarded formulation metformin ( n=29 ) placebo ( n=29 ) . Continuation stable dos MTX ( 25mg/week ) , NSAIDs , and/or corticosteroid ( prednisone &lt; 10 mg/day ) permit . Metformin drug pause day MTX give . Folic acid supplementation give group . The primary clinical endpoint ACR 20 % ( ACR20 ) response 24 week . Secondary endpoint include reduction PASI score , Health Assessment Questionnaire- Disability Index ( HAQ-DI ) Psoriatic arthritis response criterion ( PsARC ) score .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Psoriatic arthritis patient inflammatory condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>psoriatic arthritis</keyword>
	<keyword>inflammation</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>metformin</keyword>
</DOC>